Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of IncobotulinumtoxinA for Jawline Acne (Split-Face, Randomized Study)
TCTR20251231002Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in acne vulgaris, sponsored by Ramathibodi Hospital. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20251231002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251231002.